ChemPartner will be attending the IBC’s Antibody Engineering & Therapeutics 2015!

Chempartner will be attending the IBC’s Antibody Engineering & Therapeutics which is the largest and most trusted antibody engineering and therapeutics event in the industry in San Diego on December 7th-10th, 2015.

Welcome to visit our booth and posters at this great event!

http://www.ibclifesciences.com/AntibodyEng/overview.xml
Antibody Discovery in Chempartner

In ChemPartner Antibody Discovery team, over 160 scientists, 30 of which are PhD/MDs, aim to cover all the areas where our clients have needs. Our scientists are capable of discovering novel high-affinity monoclonal antibodies by hybridoma technology and single chain phage display technology. They can also develop humanized mouse monoclonal antibodies, affinity matured monoclonal antibodies and antibody-drug conjugates.
About IBC’s Antibody Engineering & Therapeutics

IBC’s Antibody Engineering & Therapeutics conference and exhibition is the #1 forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders. For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs.